Capital World Investors Sells 284,323 Shares of Veeva Systems Inc. $VEEV

Capital World Investors lowered its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 42.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 385,356 shares of the technology company’s stock after selling 284,323 shares during the quarter. Capital World Investors’ holdings in Veeva Systems were worth $86,023,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Raiffeisen Bank International AG purchased a new stake in shares of Veeva Systems during the third quarter worth about $28,000. Board of the Pension Protection Fund purchased a new stake in shares of Veeva Systems during the fourth quarter worth about $27,000. Newbridge Financial Services Group Inc. grew its position in shares of Veeva Systems by 322.6% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock worth $29,000 after purchasing an additional 100 shares in the last quarter. Activest Wealth Management grew its position in shares of Veeva Systems by 3,175.0% during the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock worth $29,000 after purchasing an additional 127 shares in the last quarter. Finally, BOK Financial Private Wealth Inc. purchased a new stake in shares of Veeva Systems during the fourth quarter worth about $33,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on VEEV shares. Stifel Nicolaus cut their target price on Veeva Systems from $245.00 to $230.00 and set a “buy” rating for the company in a research report on Thursday, June 4th. Morgan Stanley increased their target price on Veeva Systems from $205.00 to $215.00 and gave the stock an “equal weight” rating in a research report on Thursday, March 5th. BTIG Research reiterated a “buy” rating and set a $340.00 target price on shares of Veeva Systems in a research report on Thursday, June 4th. Truist Financial reiterated a “buy” rating and set a $262.00 target price (down from $275.00) on shares of Veeva Systems in a research report on Thursday, March 5th. Finally, Citigroup raised their price target on Veeva Systems from $176.00 to $190.00 and gave the company a “neutral” rating in a report on Thursday, June 4th. Eighteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $250.96.

Veeva Systems Stock Performance

Shares of Veeva Systems stock opened at $167.78 on Wednesday. The stock has a market cap of $27.40 billion, a price-to-earnings ratio of 29.91, a price-to-earnings-growth ratio of 0.74 and a beta of 0.95. The stock has a 50 day moving average price of $165.84 and a 200-day moving average price of $193.68. Veeva Systems Inc. has a one year low of $148.05 and a one year high of $310.50.

Veeva Systems (NYSE:VEEV) last announced its earnings results on Wednesday, June 3rd. The technology company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. The firm had revenue of $882.95 million during the quarter, compared to analysts’ expectations of $857.73 million. Veeva Systems had a return on equity of 13.72% and a net margin of 28.37%.The company’s quarterly revenue was up 16.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.97 EPS. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. Sell-side analysts predict that Veeva Systems Inc. will post 6.46 earnings per share for the current fiscal year.

Trending Headlines about Veeva Systems

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva announced that UCB is unifying its global pharmacovigilance and safety operations on the Veeva Safety Suite, which should help validate the platform, deepen customer usage, and support future recurring revenue. UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
• Positive Sentiment: Analyst-focused articles highlighted Veeva’s bullish Wall Street view, including an average price target implying substantial upside and a positive trend in earnings estimate revisions, which can reinforce investor confidence. Wall Street Analysts Predict a 41.87% Upside in Veeva (VEEV): Here’s What You Should Know
• Positive Sentiment: Zacks also described Veeva as a strong momentum stock, suggesting the shares are benefiting from favorable technical and sentiment trends. Here’s Why Veeva Systems (VEEV) is a Strong Momentum Stock
• Neutral Sentiment: Coverage of Veeva’s Falcon and Vault AI products noted that the tools expand workflow automation in life sciences, but management expects AI revenue to remain immaterial in fiscal 2027, limiting the near-term financial impact. Veeva’s Falcon and Vault AI: When Could AI Become a Revenue Driver?
• Neutral Sentiment: Additional articles repeated the same AI and analyst themes, adding little new fundamental news for Veeva Systems. Veeva’s Falcon and Vault AI: When Could AI Become a Revenue Driver?

Insider Activity at Veeva Systems

In other news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction that occurred on Thursday, April 30th. The stock was sold at an average price of $155.64, for a total value of $116,730.00. Following the completion of the transaction, the director owned 3,253 shares in the company, valued at approximately $506,296.92. The trade was a 18.74% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.60% of the company’s stock.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.